Polypharmacy definition and prevalence in heart failure: a systematic review

J Beezer, M Al Hatrushi, A Husband, A Kurdi… - Heart failure …, 2022 - Springer
Polypharmacy and heart failure are becoming increasingly common due to an ageing
population and the rise of multimorbidity. Treating heart failure necessitates prescribing of …

Deprescribing in older adults with cardiovascular disease

A Krishnaswami, MA Steinman, P Goyal… - Journal of the American …, 2019 - jacc.org
Deprescribing, an integral component of a continuum of good prescribing practices, is the
process of medication withdrawal or dose reduction to correct or prevent medication-related …

Virtual visits for care of patients with heart failure in the era of COVID-19: a statement from the Heart Failure Society of America

EZ Gorodeski, P Goyal, ZL Cox, JT Thibodeau… - Journal of Cardiac …, 2020 - Elsevier
In response to the COVID-19 pandemic, US federal and state governments have
implemented wide-ranging stay-at-home recommendations as a means to reduce spread of …

Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events

DL Weir, TC Lee, EG McDonald… - Journal of the …, 2020 - Wiley Online Library
BACKGROUND Admission to hospital provides the opportunity to review patient
medications; however, the extent to which the safety of drug regimens changes after …

Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status

A Peikert, P Goyal, M Vaduganathan, BL Claggett… - Heart Failure, 2023 - jacc.org
Background Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

[HTML][HTML] Clinical perspectives on cardiac rehabilitation after heart failure in elderly patients with frailty: a narrative review

D Tsukakoshi, S Yamamoto, S Takeda… - … and Clinical Risk …, 2022 - ncbi.nlm.nih.gov
The purpose of this narrative review is to examine rehabilitation modalities for patients with
heart failure and Frailty who require comprehensive intervention. Ischemic heart disease is …

Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey …

PJ Kennel, J Kneifati-Hayek, J Bryan… - BMC cardiovascular …, 2019 - Springer
Background While an expanding armamentarium of pharmacologic therapies has
contributed to improved outcomes among adults with heart failure (HF) over the past two …

Social determinants of health and 30-day readmissions among adults hospitalized for heart failure in the REGARDS study

MR Sterling, JB Ringel, LC Pinheiro… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: It is not known which social determinants of health (SDOH) impact 30-day
readmission after a heart failure (HF) hospitalization among older adults. We examined the …

Cognitive impairment in heart failure: A Heart Failure Society of America scientific statement

P Goyal, RJ Didomenico, SJ Pressler, C Ibeh… - Journal of Cardiac …, 2024 - Elsevier
Cognitive impairment is common among adults with heart failure (HF), as both diseases are
strongly related to advancing age and multimorbidity (including both cardiovascular and …

[PDF][PDF] Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial

Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - British Journal of …, 2020 - bjgp.org
Background Polypharmacy is common in heart failure (HF), whereas its effect on adverse
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …